Axel Mark Inc.
Notice Regarding Potential Incollectibility of Claims in Consolidated Subsidiaries
Public disclosure of potential incollectibility of a loan of 3,000 thousand yen held by consolidated subsidiary Axel Medicа. Expectation to record allowance for loan losses within the current term; sales in Beauty & Wellness business projected to temporarily approach zero due to dissolution and special liquidation of the subsidiary.
Key Figures
- Loans: 3,000 thousand yen (risk amount of incollectibility)
- Ratio to consolidated net assets: 0.37％
- Maturity date: August 18, 2026
AI要約
Key points of the news
Axel Mark Co., Ltd.'s wholly owned subsidiary Axel Medicа Co., Ltd. publicly discloses the potential incollectibility of a loan of 3,000 thousand yen. The process of recording allowances and decisions on dissolution and special liquidation are underway, and sales of the Beauty & Wellness business are expected to temporarily decline significantly until recovery.
Future actions and impact
As an impact on the consolidated accounts, the related receivable is planned to be fully recognized as an allowance for loan losses or as a loan loss in fiscal 2026. Review internal credit judgment, lending procedures, and monitoring framework, and promptly implement preventive measures. Due to the dissolution and special liquidation of Axel Medicа, sales of the core business in the group’s growth strategy are expected to temporarily drop to near zero.
Axel Mark Inc.
Company overview · Stock price · Financial data · All IR
